Chancellor Michael F. Collins was named one of the 50 most powerful people in the Central Massachusetts business community.
Vitiligo expert John Harris, MD, PhD, associate professor of medicine, raised awareness and addressed misconceptions about the skin condition vitiligo in an interview with Mallika Marshall, MD.
Terence R. Flotte, MD, the Celia and Isaac Haidak Professor of Medical Education, executive deputy chancellor, provost and dean of the School of Medicine, and Wen Xue, PhD, assistant professor RNA therapeutics, demonstrate a proof-of-concept for using CRISPR/Cas9 genome editing technology to correct the gene mutation responsible for alpha-1 antitrypsin (AAT) deficiency, successfully making a targeted gene correction in the livers of affected mice that restored at least low levels of normal AAT.
In an effort to discourage parents from sleeping in the same bed as their newborns, Sara Shields, MD, professor of family medicine & community health, and UMass Medical School are collaborating with local community health organizations to give away “baby boxes.”
Chancellor Michael F. Collins calls for the nation to unite around the children separated from their parents at the U.S. border, urging Americans to send nurses, physicians and mental health specialists as well as clothing and food to their aid, in an op-ed.
Co-investigators Barbara Olendzki, RD, MPH, associate professor of medicine in the Division of Preventive & Behavioral Medicine, and Ana Maldonado-Contreras, PhD, instructor in microbiology & physiological systems, are looking at the intersection of diet with microbial changes in the gut to understand how diet impacts bacterial communities, and the effects these microbial changes have on patients suffering the debilitating symptoms of inflammatory bowel disease.
UMass Medical School hosts more than 350 people from the medical field and academics for an international conference on RNA a critical molecule in gene studies.
Boston Marathoner Claire Cole Pelletier raised money for the UMass ALS Cellucci Fund.
Suzanne Wood, sustainability and energy efficiency manager, talks about Earth Day at UMass Medical School and how the medical school has saved more than 5 tons of recyclables from going into landfills through the Surplus with a Purpose program (mark 4:40).
A team of five running the Boston Marathon April 16 in honor of a loved one raised more than double its goal for the UMass ALS Cellucci Fund, nearly $79,000.
Lifeline4Moms, a new tool for assessing perinatal depression in women and guiding them to treatment was co-developed and is being tested by Nancy Byatt, DO, MS, MBA, associate professor of psychiatry, obstetrics & gynecology and quantitative health sciences and medical director for MCPAP for Moms, and Tiffany Moore Simas, MD, MPH, MEd, associate professor of obstetrics & gynecology, pediatrics, psychiatry and quantitative health science.
Tina Grosowsky, project coordinator for the Central Massachusetts Tobacco-Free Community Partnership, is quoted in a story about Worcester considering restrictions on the sales of flavored tobacco products.
A new version of Gov. Charlie Baker’s proposed Massachusetts Life Sciences Investment Fund, which will continue a decade-long initiative launched by former Gov. Deval Patrick, includes more than $50 million in funding for research at UMass Medical School.
Medical students Laura Schwartz, SOM ’21, and Rose Schutzberg, SOM ’21, participated in and commented on a student protest organized to bring an end to police violence committed against African-Americans.
Heather C. Forkey, MD, the Joy McCann Professor for Women in Medicine, associate professor of pediatrics and division chief of child protection, and Jessica Griffin, PsyD, associate professor of psychiatry, discuss the increasing number of child abuse cases in Central Massachusetts.
Rich Kennedy, who has run the Boston Marathon 31 times, is now battling ALS and raising money to fight the disease. Money raised by him goes to the The Angel Fund for ALS Research, which supports ALS research by Robert H. Brown Jr., DPhil, MD, the Leo P. and Theresa M. LaChance Chair in Medical Research and chair and professor of neurology.
Huda Y. Zoghbi, MD, professor of pediatrics, molecular and human genetics, neurology, and neuroscience at Baylor College of Medicine, will speak at the medical school’s 2018 Commencement exercises.
A Phase I clinical trial testing the safety of vaccines developed by Shan Lu, MD, PhD, professor of medicine, that might have the potential to prevent HIV infection will begin this month at four sites in the United States.
Terence R. Flotte, MD, the Celia and Isaac Haidak Professor of Medical Education, executive deputy chancellor, provost and dean of the School of Medicine, comments on the challenges remaining to turn potential gene therapies into clinical treatments.